Immortabio is a biotechnology company developing AI-enabled personalized therapeutics to treat diseases of aging.
Immorta Bio has raised $613K in total funding. The most recent round was Seed. The last funding was announced in October 2026.
Immorta Bio is headquartered in Miami Beach, United States.
Immortabio is a biotechnology company developing AI-enabled personalized therapeutics to treat diseases of aging.
Immorta Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Immorta Bio — Funding & Investors." VCBacked, October 16, 2026, https://www.vcbacked.co/company/immorta-bio. Accessed November 14, 2026.
VCBacked. (2026). Immorta Bio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/immorta-bio
{{cite web |title=Immorta Bio — Funding & Investors |url=https://www.vcbacked.co/company/immorta-bio |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Immorta Bio? Request a listing update